Americans are having a few regrets about their approach to child safety in the care of drug-using parents. Earlier this month, Gov. Michelle Lujan Grisham of New Mexico said she never should have ...
A decision by Canada’s Drug Agency will make it more difficult for Canadians to access a drug shown to slow Alzheimer’s disease in some people, says an Ottawa cognitive neurologist and researcher. Dr.
An informational consumer overview of Zealthy's prescription hydroquinone program, including compounded medication status, FDA context, telehealth dermatology consultation details, subscription and ...
Disc Medicine is laying off about 20% of its workforce after the Food and Drug Administration denied its application for accelerated approval of its bitopertin treatment.
Expanded skin analysis and physician-guided treatment planning now available at PURE locations in Chicago, Skokie, ...
Neighborhood groups are mobilizing against any proposal that would bring supportive housing and addiction treatment to the campus.
Over the past year, RenovoRx has Tripled Commercially Active U.S. Cancer Centers and Centers Requesting Access to RenovoCath, its FDA-Cleared Device ...
Sanofi and Regeneron's Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment If approved, Dupixent would be the first ...
A Massachusetts woman knew the medicine her doctor prescribed required preauthorization, but she didn’t realize the approval had an expiration date. It took nearly three weeks of phone calls and ...
We're transitioning from building a pipeline to building a business." He highlighted the successful launch of PALSONIFY as the company's first commercial product and emphasized its label reflecting ...
Struggling with depression? NeuroStar TMS at Northeast Health Services offers safe, effective, FDA-cleared, non-drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results